Filters
Hamburg Regional Court: validity of the presumption of availability in maintenance contracts
Online coaching and distance learning: Federal Court of Justice clarifies application of the Distance Learning Protection Act
Impact of the new Biotech Act on Clinical Trials in the EU
A European Perspective #1 | EU Biotech Act: Faster Clinical Trial Approvals Ahead | The European Commission’s proposed Biotech Act aims to streamline clinical trial procedures, shorten approval timelines, and harmonise data protection rules across the EU. If adopted, the reform could significantly accelerate multinational clinical research in the EU.
4 of 9 Insights
The 2026 Pharma Package: A New Regulatory Framework for Medicinal Products in the EU
A European Perspective #1 | The EU’s largest pharmaceutical law reform in over 20 years introduces a new regulatory exclusivity framework, revised orphan drug incentives and an antimicrobial voucher. Strategic exclusivity planning will become essential for pharmaceutical companies.
1 of 9 Insights
Climate-based claims against car manufacturers: The Federal Court of Justice (BGH) has dismissed the climate lawsuits brought by DUH
Navigating CRD VI: Third country branch regime and its impact on cross-border lending
Taylor Wessing strengthens Corporate/M&A practice with Equity Partner Jan Hückel
German Federal Court of Justice promotes Legal Certainty for Leaver Clauses in Management Equity Programs in the Private Equity Sector
No claim for damages as a result of participation in clinical drug trials
A European Perspective #1 | GERMANY | The Frankfurt am Main Regional Court confirms: No reduction in the burden of proof (presumption of causality) pursuant to Section 84 (2) of the German Medicines Act (AMG) for IMP (not even by analogy) and no liability on the part of the sponsor in the event of (insufficient) risk information provided by the investigating physician.
7 of 9 Insights
